National Health Investors (NYSE:NHI) Hits New 52-Week High – Should You Buy?

National Health Investors, Inc. (NYSE:NHI) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $80.68 and last traded at $80.65, with a volume of 30272 shares trading hands. The stock had previously closed at $79.23.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on NHI. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a report on Monday, January 5th. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. National Bankshares set a $90.00 target price on National Health Investors in a research note on Wednesday, October 1st. Wells Fargo & Company lifted their target price on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Finally, Truist Financial increased their price target on shares of National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $86.50.

National Health Investors Stock Up 1.8%

The stock has a market cap of $3.84 billion, a P/E ratio of 25.43, a P/E/G ratio of 2.92 and a beta of 0.67. The company has a quick ratio of 10.64, a current ratio of 10.64 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $77.64 and a two-hundred day simple moving average of $75.85.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. The company had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The firm’s revenue was down 1.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, equities analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. National Health Investors’s payout ratio is currently 116.09%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of National Health Investors by 0.8% during the third quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock valued at $516,624,000 after purchasing an additional 52,474 shares in the last quarter. State Street Corp lifted its position in National Health Investors by 5.0% during the second quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after buying an additional 95,812 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of National Health Investors by 34.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after buying an additional 409,559 shares in the last quarter. Geode Capital Management LLC grew its position in shares of National Health Investors by 4.5% in the 2nd quarter. Geode Capital Management LLC now owns 1,232,524 shares of the real estate investment trust’s stock worth $86,434,000 after buying an additional 53,630 shares during the period. Finally, Centersquare Investment Management LLC increased its stake in shares of National Health Investors by 21.8% in the 3rd quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock worth $78,443,000 after acquiring an additional 176,410 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.